TraceLink VP Jerry Meyer was named a 2026 'Pros to Know' honoree for advancing governed, production-ready agentic AI in life sciences supply chains. His leadership transformed OPUS into a metadata-driven, no-code digital backbone—cutting capability deployment from months to weeks. The platform now supports AI Assistants and Agents in exception management, procure-to-pay, order-to-cash, supply assurance, and multienterprise coordination—with full GxP auditability. TraceLink’s network connects over 291,000 healthcare and life sciences entities.
According to www.prnewswire.com, TraceLink Vice President of OPUS Core Platform Development Jerry Meyer has been named a 2026 Supply & Demand Chain Executive “Pros to Know” honoree in the Leaders in Excellence category. The award recognizes his leadership in advancing governed, production-ready agentic AI and digital orchestration across regulated life sciences supply chains.
A Unified Foundation for AI-Driven Orchestration
Meyer oversees the architecture of the Orchestration Platform for Universal Solutions (OPUS), TraceLink’s industrial-grade multienterprise platform enabling secure, governed collaboration across global life sciences and healthcare networks. Under his leadership, OPUS evolved from a compliance-focused system into a metadata-driven, no-code digital backbone—reducing deployment timelines for new capabilities from months to weeks. This infrastructure structures multienterprise processes, partner interactions, and regulatory requirements into governed, interoperable workflows.
Governed Agentic AI Embedded in Operational Workflows
Meyer and his team embedded governed agentic AI directly into customer and trade partner solutions natively—ensuring AI operates on structured process definitions, role-based controls, and auditable transaction data. This approach enables automation within defined responsibilities, domain intelligence, human oversight, and full auditability. As a result, TraceLink launched its first production AI Assistants and Agents for exception management, procure-to-pay, order-to-cash, supply assurance, and multienterprise coordination.
“The future of regulated supply chains is agentic, intelligent, and network-driven.” — Shabbir Dahod, President and CEO of TraceLink
“Building an effective agentic workforce requires more than just AI models—it requires the right architecture. The quality and flexibility of your no-code AI agent framework ultimately defines the quality of your digital workforce.” — Jerry Meyer, Vice President of OPUS Core Platform Development, TraceLink
- TraceLink links more than 291,000 healthcare and life sciences entities via its Business-to-Network Integrate-Once™ network
- OPUS combines an integrated information backbone across internal and external supply chain systems, governed AI with full GxP auditability, and a no-code framework for defining agents through structured roles and operating procedures
- The platform enables real-time adaptation to changing global regulatory requirements, reduces disruption risk, and translates regulatory readiness into operational agility, resilience, and competitive advantage
For supply chain professionals in life sciences and healthcare, Meyer’s work signals a practical shift: AI is no longer experimental or siloed. It is now embedded in production environments where traceability, accountability, and auditability are non-negotiable. The OPUS platform allows organizations to integrate once—and then rapidly deploy AI agents across procurement, logistics, quality, and regulatory functions without rebuilding legacy interfaces. This reduces time-to-value for AI use cases while preserving compliance integrity—a critical differentiator in GxP-regulated environments. As industry peers like Pfizer and Roche accelerate AI adoption in supply chain planning and serialization, TraceLink’s production-scale agentic architecture offers a replicable model for governed, cross-enterprise execution.
Source: www.prnewswire.com
Compiled from international media by the SCI.AI editorial team.
